Skip to main content
Erschienen in: BMC Public Health 1/2010

Open Access 01.12.2010 | Research article

Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy

verfasst von: Claudio Pelucchi, Susanna Esposito, Carlotta Galeone, Margherita Semino, Caterina Sabatini, Irene Picciolli, Silvia Consolo, Gregorio Milani, Nicola Principi

Erschienen in: BMC Public Health | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

In order to be widely accepted by users, the implementation of a new health intervention requires them to be adequately informed about its clinical importance, benefits and risks. The aim of this study was to provide data on the knowledge of Italian adolescents and parents concerning human papillomavirus (HPV) infection and its prevention in order to allow the development of adequate training programmes.

Methods

Between 2 May and 15 June 2008, we made a cross-sectional survey of 863 high school students and 2,331 parents of middle and high school students using two anonymously completed questionnaires covering the knowledge of HPV infection and related diseases, and attitudes to vaccinations. The approached schools were a convenience sample of the schools of the greater Milan area, Northern Italy.

Results

More mothers than fathers were aware that HPV infection could concern their children (58% vs 53%; p = 0.004) and were favourable towards vaccinating their children against HPV (68% vs 65%; p = 0.03); among the students, more females than males were aware that HPV infection could concern themselves (45% vs 26%; p < 0.001) and would undergo vaccination against HPV (68% vs 40%; p < 0.001). The parents' propensity to vaccinate their children against HPV was significantly associated with professing the Catholic religion (odds ratio - OR = 0.61, 95% confidence interval - CI 0.46-0.82, being atheist), the gender of the offspring (OR = 1.88, 95% CI 1.53-2.30, having at least one daughter), a propensity to vaccinations in general (OR = 23.1, 95% CI 13.7-38.8), a knowledge that HPV vaccine is aimed at preventing cervical cancer (OR = 2.31, 95% CI 1.69-3.16), and an awareness that HPV could affect their own children (OR = 3.52, 95% CI 2.89-4.29). The students who were aware that HPV infection could affect themselves were more in favour of to HPV vaccination, regardless of whether they were male (OR = 5.73, 95% CI 2.85-11.5) or female (OR = 2.39, 95% CI 1.66-3.46).

Conclusions

Both students and parents seem to underestimate the likelihood of HPV infection, and this is associated with a lower propensity for vaccination. This is an important indication for future training programmes concerning HPV prevention designed to increase the acceptance of HPV vaccine in families.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2458-10-378) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CP, created the database and wrote the manuscript. SE, designed the study and co-wrote the manuscript. CG, performed the statistical analysis. MS, CS, IP, SC, and GM, explained and collected the questionnaires. NP, designed the study and co-wrote the manuscript.
All authors read and approved the final manuscript.
Abkürzungen
CI
confidence interval
HPV
human papillomavirus
OR
odds ratio.

Background

Persistent infection with high-risk human papillomavirus (HPV) can cause cancers of the cervix and other genital sites, anus, oral cavity and oropharynx, and possibly the larynx and skin [16].
In March 2008, the Italian Ministry of Health suggested to the Vaccine Committee of the Regions to start an active, free vaccination campaign against HPV as cause of cervical cancer aimed at 12-year old girls in line with the guidelines of a number of other industrialised countries [7, 8]. The choice of this age was based on findings that HPV infection is almost exclusively due to sexual contact, that a large proportion of subjects are first infected during adolescence or early adulthood [9, 10], and that the immune response to HPV vaccination is higher in younger subjects [11]. Moreover, the available vaccines against HPV types 16 and 18 (i.e. those associated with the highest risk of cancer) have no therapeutic effect against already established infection and HPV-associated diseases [12]. However, HPV vaccination is also indicated in older teenagers who have not yet (or have only just) started sexual activity, and might even be considered in women aged more than 25 years [11, 13, 14]. This explains why some Italian Regions, although maintained cervical cancer prevention as the primary purpose of prevention programme, extended the free vaccination campaign to young people aged 15 or 16 years, and others are offering older teenagers a discount on the price of HPV vaccination.
In order to be widely accepted by users, the implementation of a new health intervention requires them to be adequately informed about its clinical importance, benefits and risks. HPV vaccination is more complex than other health initiatives because the targets are young, decisions are generally made by their parents, and may not be based on reliable information. Moreover, even when younger subjects are still being followed by pediatricians, the physicians may be poorly informed about HPV-related diseases because most of these occur in adulthood [15]. In order to be successful, HPV vaccination programmes therefore need to educate not only the targets, but also their parents and healthcare providers.
This means previously acquiring adequate information concerning the knowledge and attitudes of the different subjects involved. A number of investigations carried out in different parts of the world have shown that such subjects are inadequately aware of the problem [1522], although most of the surveys of adults' knowledge of HPV did not focus on their parental role. Furthermore, little information is available concerning Italian teenagers' and parents' knowledge of, and attitude towards HPV infection and its prevention [18, 19]. Considering the importance of communication and educational material in improving vaccination coverage [2326], the aim of this study of a large number of high school students and parents of middle and high school students was to provide some of the basic data necessary for the development of adequate training programs.

Methods

Between 2 May and 15 June 2008, we carried out a cross-sectional survey of high school students and parents of middle and high school students in order to verify their knowledge of HPV infection and HPV-related diseases, and their attitudes to vaccinations (particularly HPV vaccine).
The survey involved two middle schools in Milan (one private and one state run), five high schools specialising in classical, linguistic or scientific studies (two private and three state run) in the greater Milan area and Varese, and one state-run technical school in Milan. The schools were a convenience sample chosen on the basis of contacts of the authors of this paper with school boards. We varied the type of schools included in the investigation in order to obtain a composite distribution of subjects reflecting the characteristics of the baseline population, with specific reference to age of the students and educational level of the parents. S.E. and N.P. had repeated contacts with boards of each school before the distribution of the questionnaires in order to assure the best compliance of teachers to the survey. After the study had been approved by the Ethics Committee of Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, and the boards of each school, all of the students attending the high schools were given three questionnaires: one for the student and one for each parent. Because of the age of the students attending the middle schools (10-13 years), school boards decided that only their parents had to complete a questionnaire.
The students' and parents' questionnaires were designed to collect information concerning the compilers' knowledge of HPV infection and their attitudes to vaccination. Both were to be anonymously self-completed (at home), and were accompanied by a formal letter describing the aims of the study and explaining how to complete the questionnaires. The same information was also given orally when the questionnaires were given to the students.
The questionnaires, that were prepared by a multidisciplinary group including pediatricians (SE, NP) and epidemiologists (CP, CG), were pilot-tested on a convenience sample of adolescents and parents attending the outpatient clinic of the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan in order to ensure clarity and ease of administration. The student questionnaire [Additional file 1] had four sections covering: 1) demographic and socio-economic characteristics such as age, race, religion, number of siblings, and the education and occupation of the parents; 2) HPV infection (its perceived dangerousness and modes of transmission) and vaccination (including preventable diseases, age at vaccination, and favourite source of vaccine information); 3) their willingness to be vaccinated against HPV; and 4) their sexual activity and attitudes to discussing sexual health issues. The parent questionnaire [Additional file 2] had five sections covering: 1) demographic and socio-economic characteristics such as age, race, religion, number and age of children, education and occupation, and family history of cancer; 2) attitudes towards vaccinations in general; 3) HPV infection and HPV vaccination; 4) their willingness to have their children vaccinated against HPV; and 5) their attitudes to discussing sexual health issues with their children and informing them about HPV infection and vaccination. The items for students were presented in an easier way, but covered aspects similar to that asked to the parents.
The students had to return the questionnaires to their teachers within a week of their distribution, and the completed questionnaires were collected from the schools by members of the research team.
The responses were analysed by means of descriptive statistics. In the case of categorical data, the gender groups (mothers vs fathers among parents and females vs males among students) were compared using the χ 2 or Fisher's exact test as appropriate. All of the analyses were two tailed, and p values of 0.05 or less were considered significant. Odds ratios (OR) and 95% confidence intervals (CI) were calculated in order to measure the associations between selected factors chosen on the basis of literature review and the parents' propensity to have their children vaccinated against HPV, or the students' propensity to undergo HPV vaccination themselves. The ORs were obtained by means of unconditional multiple logistic regression adjusted for: 1) age, education, gender and religion of the parents, and age and gender of their children in the case of the parents' data; or 2) age and religion of the student and education of the parents in the case of the students' data. All of the analyses were made using SAS version 9.1 (Cary, NC, USA).

Results and discussion

A total of 3,026 questionnaires were distributed to parents (1,520 to mothers and 1,506 to fathers), 2,331 (77.0%) of which were returned with more than 70% of the questions answered. The students received a total of 1,092 questionnaires (691 given to females and 401 to males), 863 (79.0%) of which were returned with more than 70% of the questions answered. There was no difference in the response rates of the mothers and fathers, whereas female students answered significantly more frequently than male students (93.9% vs 52.1%; p < 0.0001). There was also no significant difference in response rates and data obtained in the different schools.
Table 1 shows the distribution of the 2,331 parents who participated in the survey on the basis of selected socio-demographic characteristics. Fathers were older than mothers: respectively 44% and 23% were aged 50 years. Forty-one percent of the parents had a university degree. Twenty-three percent had only one child, 56% two children, and 21% three or more; 11% had at least one child aged <12 years, while the modal age of their children was 16-17 years (32%). Most of the parents had at least one daughter involved in the survey (72%).
Table 1
Distribution of parents by gender, age and selected socio-demographic characteristics
 
Mothers (n = 1225)
Fathers (n = 1093)
All (n = 2331)a
 
No.
%
No.
%
No.
%
Age (years)
      
<40
93
7.6
37
3.4
130
5.6
40-44
348
28.4
173
15.8
521
22.4
45-49
488
39.8
390
35.7
885
38.0
≥50
282
23.0
476
43.5
759
32.5
Missing values
14
1.2
17
1.6
36
1.5
Mean age ± SD (years)
46.1 ± 5.6
 
49.1 ± 5.6
 
47.5 ± 5.4
 
Education
      
Middle school diploma
176
14.4
222
20.3
398
17.1
High school diploma
564
46.0
406
37.0
973
41.7
Degree
475
38.8
462
42.4
944
40.5
Missing values
10
0.8
3
0.3
16
0.7
No. of children
      
1
292
23.8
249
22.8
544
23.3
2
681
55.6
610
55.8
1296
55.6
3
198
16.2
180
16.5
380
16.4
≥4
50
4.1
52
4.8
103
4.4
Missing values
4
0.3
2
0.1
8
0.3
Age of child(ren) involved in the study b (years)
      
<12
143
11.7
118
10.8
261
11.2
12-13
262
21.4
236
21.6
501
21.5
14-15
303
24.7
278
25.4
582
25.0
16-17
384
31.3
337
30.8
725
31.1
≥18
112
9.2
105
9.7
220
9.4
Missing values
21
1.7
19
1.7
42
1.8
Gender of child(ren) involved in the study
      
Male
341
27.8
298
27.3
641
27.5
Female
821
67.0
719
65.8
1549
66.5
Both
57
4.7
65
5.9
122
5.2
Missing values
6
0.5
11
1.0
19
0.8
SD, standard deviation. a Thirteen parents did not answer the question concerning gender. b When more than one offspring was involved, the age of the youngest is given.
Table 2 shows the distribution of the 863 students participating in the survey on the basis of selected socio-demographic characteristics. Age distribution was similar among the males and females: the age range was 14-20 years, and the mean age 16.1 years. Most had only one sibling (55%), or were the only child in the family (22%).
Table 2
Distribution of students by gender, age and selected socio-demographic characteristics
 
Females
(n = 649)
 
Males
(n = 209)
 
All
(n = 863)a
 
 
No.
%
No.
%
No.
%
Age (years)
      
14-15
231
35.6
85
40.7
317
36.7
16-17
309
47.6
92
44.0
402
46.6
≥18
107
16.5
30
14.3
137
15.9
Missing values
2
0.3
2
1.0
7
0.8
Mean age ± SD (years)
16.2 ± 1.44
 
16.0 ± 1.59
 
16.1 ± 1.48
 
Education (mother)
      
Middle school diploma
133
20.5
28
13.4
161
18.7
High school diploma
312
48.1
93
44.5
408
47.3
Degree
191
29.4
85
40.7
278
32.1
Missing values
13
2.0
3
1.4
16
1.9
Education (father)
      
Middle school diploma
148
22.8
32
15.3
180
20.9
High school diploma
242
37.3
62
29.7
308
35.7
Degree
239
36.8
108
51.7
348
40.3
Missing values
20
3.1
7
3.3
27
3.1
No. of siblings
      
0
150
23.1
41
19.6
194
22.5
1
359
55.3
115
55.0
476
55.2
2
104
16.1
38
18.2
142
16.4
≥3
36
5.5
15
7.2
51
5.9
SD, standard deviation. a Five students did not answer the question concerning gender.
Table 3 shows the distribution of the parents' and students' answers concerning their personal knowledge of HPV infection and vaccination, by gender. Mothers had ever heard of HPV more frequently than fathers (91% vs 77%; p < 0.001) and, among the parents who were aware of HPV, the mothers were also more often aware of the dangerousness of the virus (92% vs 88%; p = 0.004) and more informed as to how it is transmitted (94% vs 91%; p = 0.02). Similarly, a higher proportion of female (72%) than male students (51%; p < 0.001) had ever heard of HPV but, among those who were aware of HPV, there was no significant gender-related difference in its perceived dangerousness (about 90% in both sexes) or how it is transmitted (90% vs 92%). With reference to their knowledge of HPV vaccination, 90% of the mothers and 87% of the fathers knew that HPV vaccine is aimed at preventing cervical cancer (p = 0.02); the corresponding figures for the female and male students were 75% and 63% (p = 0.008). About 75% of the mothers, fathers and female students knew that the vaccination should be given before sexual activity begins; this decreased to 67% of the male students, although the between-gender difference among the students was not significant.
Table 3
Parents' and children's knowledge of HPV infection and vaccination, by gender.
 
Parents
    
Students
    
 
Mothers
 
Fathers
 
P value1
Females
 
Males
 
P value2
 
No.
%
No.
%
 
No.
%
No.
%
 
Have you ever heard of HPV?
          
No/Do not know
110
9.0
259
23.7
 
184
28.4
102
48.8
 
Yes
1115
91.0
834
76.9
<0.001
465
71.6
107
51.2
<0.001
Do you think HPV infection can be dangerous?
          
Yes
1026
92.0
735
88.1
 
421
90.5
96
89.7
 
No/Only when other health conditions are present/Do not know
89
8.0
99
11.9
0.004
44
9.5
11
10.3
0.80
Do you know how HPV infection is passed on?
          
Sexual intercourse
1049
94.1
762
91.4
 
421
90.5
99
92.5
 
Wrong answers/Do not know
66
5.9
72
8.6
0.02
44
9.5
8
7.5
0.52
What is the aim of HPV vaccination?
          
   To prevent cervical cancer
          
Yes
1005
90.1
723
86.7
 
350
75.3
67
62.6
 
No/Do not know
110
9.9
111
13.3
0.02
115
24.7
40
37.4
0.008
   To prevent a STD
          
Yes
104
9.3
100
12.0
 
56
12.0
15
14.0
 
No/Do not know
1011
90.7
734
88.0
0.06
409
88.0
92
86.0
0.58
When should HPV vaccination be given? 3
          
During the first year of life
36
3.2
25
3.0
0.77
14
3.0
3
2.8
1.00
Before sexual activity begins
852
76.4
621
74.5
0.32
351
75.5
72
67.3
0.08
After sexual activity has begun
57
5.1
48
5.8
0.53
37
8.0
8
7.5
0.87
STD, sexually transmitted disease. 1 Mothers vs fathers. 2 Females vs males. 3 As multiple answers were allowed, each was considered a dichotomous variable (yes/no); the numbers do not add up to the total because infrequent answers are not included.
Table 4 shows the attitudes of the parents and students to vaccination (only the parents were asked questions about vaccinations in general: i.e. not specific to HPV). Both mothers (92%) and fathers (93%) were generally in favour of vaccinations. When asked which recommendations were more important when deciding whether to have their children vaccinate, they more frequently indicated the Ministry of Health (about 48% of both mother and fathers), pediatricians (50% of mothers, 43% of fathers, p = 0.001) and other physicians (28% of mothers, 24% of fathers). The mothers were more aware than the fathers that HPV infection could affect their children (58% vs 53%, p = 0.004) and were more in favour of them being vaccinated (68% vs 65%; p = 0.03). When these last two questions were answered by the students, 45% of females and 26% of males were aware that HPV infection could concern themselves (p < 0.001), and 68% of females and 40% of males said they would undergo HPV vaccination (p < 0.001).
Table 4
Parents' and students' attitude to vaccination, by gender.
 
Parents
    
Students
    
 
Mothers
 
Fathers
 
P value1
Females
 
Males
 
P value2
 
No.
%
No.
%
 
No.
%
No.
%
 
Are you in favour of vaccinations in general? 3,4
          
No
97
8.0
72
6.7
      
Yes
1117
92.0
1009
93.3
0.22
     
Whose recommendations are significant to you when deciding on a vaccination for your children? 3,5
          
Ministry of Health
594
48.5
518
47.4
0.60
     
Regional body
41
3.3
43
3.9
0.45
     
Pediatrician
614
50.1
475
43.5
0.001
     
Other physician
343
28.0
268
24.5
0.06
     
Relative or friend
20
1.6
16
1.5
0.74
     
Teacher
5
0.4
7
0.6
0.44
     
Religious authority
6
0.5
4
0.4
0.65
     
Other
78
6.4
77
7.0
0.51
     
Do you think HPV infection might concern your children (for parents)/you (for students)? 4
          
Do not know
251
20.7
286
26.6
 
174
27.1
65
31.1
 
No
255
21.0
219
20.3
 
179
27.9
89
42.6
 
Yes
707
58.3
572
53.1
0.004
289
45.0
55
26.3
<0.001
Would you give your children (for parents)/undergo (for students) HPV vaccination HPV? 4
          
No
92
7.6
66
6.1
 
36
5.6
40
19.1
 
Perhaps
293
24.1
308
28.7
 
169
26.1
86
41.1
 
Yes
830
68.3
699
65.1
0.03
442
68.3
83
39.7
<0.001
1 Mothers vs fathers. 2 Female students vs male students. 3 Question for parents only. 4 The numbers do not add up to the total because of a few missing answers. 5 As multiple answers were allowed, each was considered a dichotomous variable (yes/no).
Table 5 shows the associations among the parents between selected factors and their attitude to HPV vaccination for their children. There was no significant association between the propensity to have their children vaccinated and the age, gender or education of the parent, or the age of their children. The parents professing a religion other than Catholicism or who were atheists were less in favour of HPV vaccination for their children (OR = 0.61, 95% CI 0.46-0.82, compared with Catholics). Significant associations with a propensity to have their children vaccinated also included the gender of the offspring (OR = 1.88, 95% CI 1.53-2.30, having at least one daughter), a propensity to vaccinations in general (OR = 23.1, 95% CI 13.7-38.8), a knowledge that HPV vaccine is aimed at preventing cervical cancer (OR = 2.31, 95% CI 1.69-3.16), and an awareness that HPV could affect their own children (OR = 3.52, 95% CI 2.89-4.29).
Table 5
Associations between selected socio-demographic factors, personal beliefs and attitudes of parents to vaccinating their children against HPV.
 
In favour of HPV vaccination (n = 1438)
Against or doubtful about HPV vaccination (n = 706)
OR (95% CI) 2
 
No.
%
No.
%
 
Age of parent (years)
     
<40
80
5.6
37
5.2
1 (reference)
40-44
319
22.2
172
24.4
0.85 (0.54-1.31)
45-49
565
39.3
265
37.5
1.04 (0.67-1.60)
≥50
474
33.0
232
32.9
1.05 (0.68-1.64)
Education
     
Middle school diploma
254
17.7
122
17.3
1 (reference)
High school diploma
616
42.8
280
39.7
1.04 (0.80-1.35)
Degree
568
39.5
304
43.1
0.91 (0.69-1.19)
Parent
     
Father
658
45.8
347
49.1
1 (reference)
Mother
780
54.2
359
50.8
1.17 (0.97-1.42)
Religion
     
Catholic
1314
91.4
608
86.1
1 (reference)
Other/no religion
124
8.6
98
13.9
0.61 (0.46-0.82)
Age of (youngest) child involved in the study (years)
     
<12
164
11.4
82
11.6
1 (reference)
12-14
434
30.2
218
30.9
1.04 (0.76-1.43)
≥15
840
58.4
406
57.5
0.93 (0.69-1.26)
Gender of child(ren) involved in the study
     
Male(s) only
336
23.4
255
36.1
1 (reference)
At least one daughter
1102
76.6
451
63.9
1.88 (1.53-2.30)
Generally in favour of vaccinations 3
     
No
17
1.2
139
20.0
1 (reference)
Yes
1416
98.8
555
80.0
23.1 (13.7-38.8)
Knows that HPV vaccine is aimed at preventing cervical cancer 3
     
No/Does not know
107
8.3
91
17.0
1 (reference)
Yes
1179
91.7
444
83.0
2.31 (1.69-3.16)
Thinks that HPV might concern own child(ren) 3
     
No/Does not know
487
34.0
449
64.0
1 (reference)
Yes
946
66.0
253
36.0
3.52 (2.89-4.29)
CI, confidence interval; OR = odds ratio. 1 The numbers of subjects are not the same as in Table 4 because those with missing information relating to one or more of the socio-demographic covariates in the models (n = 187; 8% of the total) were excluded. 2 ORs from multivariate logistic regression models, adjusted for age, education, gender and religion of parent, and age and gender of the child. 3 The numbers do not add up to the total because of missing answers.
Table 6 shows the associations among students, by gender. The age and religion of the student, and the educational level of their parents were not associated with a propensity to HPV vaccination in either the male or female students. The students who were aware that HPV infection could affect themselves were more in favour of to HPV vaccination, regardless of whether they were male (OR = 5.73, 95% CI 2.85-11.5) or female (OR = 2.39, 95% CI 1.66-3.46). The female students who declared they had a boyfriend (OR = 0.67, 95% CI 0.47-0.97) and had already experienced sexual intercourse (OR = 0.68, 95% CI 0.44-1.03) were less in favour of HPV vaccination, whereas these factors were not associated with the propensity to undergo vaccination among the male students. There was no significant association with a knowledge that HPV vaccine is aimed at preventing cervical cancer.
Table 6
Association between selected socio-demographic factors, personal beliefs and characteristics, and attitudes of students to being vaccinated against HPV, by gender.1
 
Males
  
Females
  
 
In favour of HPV vaccination (n = 78)
Against or doubtful about HPV vaccination (n = 123)
OR (95% CI) 2
In favour of HPV vaccination (n = 431)
Against or doubtful about HPV vaccination (n = 196)
OR (95% CI) 2
 
No. (%)
No. (%)
 
No. (%)
No. (%)
 
Age (years)
      
<16
29 (37.2)
55 (44.7)
1 (reference)
156 (36.2)
72 (36.7)
1 (reference)
16-17
37 (47.4)
51 (41.5)
1.40 (0.75-2.61)
198 (45.9)
100 (51.0)
0.95 (0.65-1.37)
≥18
12 (15.4)
17 (13.8)
1.38 (0.58-3.31)
77 (17.9)
24 (12.2)
1.51 (0.88-2.59)
Religion
      
Catholic
66 (84.6)
100 (81.3)
1 (reference)
382 (88.6)
165 (84.2)
1 (reference)
Other/no religion
12 (15.4)
23 (18.7)
0.77 (0.35-1.66)
49 (11.4)
31 (15.8)
0.67 (0.41-1.10)
Highest education qualification of parents
      
Middle school diploma
7 (9.0)
11 (8.9)
1 (reference)
55 (12.8)
30 (15.3)
1 (reference)
High school diploma
23 (29.5)
38 (30.9)
0.94 (0.32-2.80)
177 (41.1)
82 (41.8)
1.13 (0.67-1.91)
Degree
48 (61.5)
74 (60.2)
1.06 (0.38-2.97)
199 (46.2)
84 (42.9)
1.27 (0.76-2.14)
Thinks that HPV might concern him/her 3
      
No/Does not know
42 (53.8)
106 (86.2)
1 (reference)
207 (48.7)
136 (69.7)
1 (reference)
Yes
36 (46.1)
17 (13.8)
5.73 (2.85-11.5)
218 (51.3)
59 (30.3)
2.39 (1.66-3.46)
Has a boyfriend/girlfriend 3
      
No
52 (66.7)
83 (69.7)
1 (reference)
283 (65.8)
113 (57.6)
1 (reference)
Yes
26 (33.3)
36 (30.2)
1.16 (0.62-2.17)
147 (34.2)
83 (42.3)
0.67 (0.47-0.97)
Has had sexual intercourse 3
      
No
55 (70.5)
90 (76.3)
1 (reference)
335 (78.3)
142 (72.4)
1 (reference)
Yes
23 (29.5)
28 (23.7)
1.30 (0.65-2.62)
93 (21.7)
54 (27.5)
0.68 (0.44-1.03)
Knows that HPV vaccine is aimed at preventing cervical cancer 3
      
No/Does not know
17 (44.7)
23 (35.9)
1 (reference)
75 (23.1)
36 (28.3)
1 (reference)
Yes
21 (55.3)
41 (64.1)
0.69 (0.30-1.61)
249 (76.8)
91 (71.6)
1.26 (0.79-2.03)
CI = confidence interval; OR = odds ratio. 1 The numbers of subjects are not the same as in Table 4 because those with missing information relating to one or more of the socio-demographic covariates in the models (n = 35; 4% of the total) were excluded. 2 ORs from multivariate logistic regression models, adjusted for age and religion of child, and education of parents. 3 The numbers do not add up to the total because of missing answers.
This study of an upper-middle class population in the greater Milan area, Northern Italy, found that teenagers and parents still have a number of gaps in their knowledge of HPV infection and its prevention by means of vaccination. In particular, they seemed to underestimate the likelihood of HPV infection and were therefore less likely to see HPV vaccination favourably. This is an important indication for future family HPV training programmes designed to increase the acceptance of HPV vaccination.
Most of the parents were aware of HPV and correctly answered a number of questions about it. This might be at least partially explained by their higher education level in Northern Italy in comparison with the general Italian population [27]. There are relatively few other studies of parents, most of which have found a lower level of knowledge of HPV infection. A previous Italian study performed in Southern Italy found that 54% of the mothers of daughters aged 10-12 years had ever heard of HPV [19], and the corresponding figure in a school-based survey conducted in four areas of England was only 26% [28]. However, a US (North Carolina) study reported findings close to ours, with an 83% awareness of HPV among caregivers (mostly parents) and a 69% average of correct answers to questions about it [29].
Nevertheless, a proportion of our parents still need to be better informed about HPV-related health topics. The facts that parents, who are key decision makers in the uptake of this vaccine, are still hesitant to have their daughters receive HPV vaccine, and that strategies to ensure optimal HPV vaccine uptake need to be employed have been recently reported in a population-based evaluation in British Columbia, Canada [30]. In our study, this was especially true for the fathers, whose overall knowledge of HPV (including awareness of HPV infection and its dangerousness, despite in some cases these differences were marginal and not clinically relevant) was significantly less than that of the mothers. Once again, our findings were comparable with those of the North Carolina investigation, which found that only 54% of male caregivers knew about HPV as against 84% of female caregivers [29]. Our findings indicate that interventions aimed at increasing knowledge of HPV should involve the fathers of young children, not least because any health procedure in pediatric subjects must be authorised by both parents in Italy.
Among the students, about 70% of the females and 50% of the males had ever heard of HPV, and about 75% of the former and 66% of the latter know about the aim and mode of HPV vaccination. The data from other studies are mixed [18, 3134]. A cross sectional study of females aged 14-24 years carried out in Southern Italy found that only 30% had ever heard of HPV infection [18], and that the proportion of women who were aware that HPV vaccination is aimed at preventing cervical cancer was also low [18]. In a recent Swedish survey [35], only 5% of the first-year high students of both sexes were aware of HPV, whereas a 1999 study of US university students found that 37% of the respondents had ever heard of it [36].
However, although our findings indicated a better knowledge of HPV among students, it is of concern that only 45% of the female teenagers perceived themselves at risk of HPV infection. This might be explained by a lack of awareness of the high prevalence of HPV infection [9, 35], as has been previously found in other studies [37, 38]. Furthermore, in addition to having less knowledge of HPV, a large proportion of the male students thought that it did not concern them. This is maybe not surprising as HPV infection and vaccination have almost exclusively been publicised in relation to the prevention of cervical cancer, and it is still being discussed whether males should also be vaccinated [39, 40]. Teenagers of both sexes therefore need further information.
We found that the attitude of both parents to vaccinations was very positive, not only because the overwhelming majority were in favour of vaccination in general, but also because about two-thirds said they were in favour of a new vaccination against HPV, even though complete data on the vaccine are not yet available. Fewer than 7% of the parents declared they were certainly against the vaccination, and similarly encouraging results were found among the female students. It is interesting to note that 47% of the parents named pediatricians as their preferred counsellor in the case of decisions concerning vaccinations, and 65% of those with children aged aged <12 years. The recommendation of other physicians (mainly family doctors) was important for 26%, and so these might also play a major role in decision making. In agreement with previous studies [4145], these data suggest that programmes aimed at increasing vaccination coverage should also involve pediatricians or family physicians depending on the age of the target.
Another finding was that parents consider the indications of the Ministry of Health (48%) rather than Regional institutions (about 3%) as a reference for decision making. This highlights the fact that the general population does not realise that recommendations concerning vaccines (and the availability of free vaccinations) is determined not centrally but at Regional level in Italy.
The main factors associated with the parents' propensity to accept HPV vaccination were: 1) having at least one daughter; 2) being in favour of vaccinations in general; 3) knowing that the vaccine is aimed at preventing cervical cancer; and 4) being aware that their children could be infected by HPV (this association was particularly strong). As also found by other studies [4649], there was also a positive association between the perceived likelihood of HPV infection and the propensity of both male and female students to undergo vaccination [4649]. This supports that the first target for the success of HPV vaccination campaign should be to increase adolescents' and parents' knowledge on this topic, particularly underlining the frequency of HPV. Although the association was not statistically significant, our findings also indicated that mothers were more likely to favour having their children vaccinated than fathers. When all of these analyses were limited to the parents of daughters alone, the results were substantially the same.
In addition to their awareness of possible HPV infection, a few other factors were also associated with the propensity of students to undergo vaccination. In particular, having a boyfriend or having already had sexual intercourse were associated with a decreased propensity among female students, possibly because of the high proportion who knew the vaccination should be given before the start of sexual activity. However, this highlights the need for a training programme focused on the epidemiology of HPV infection in different age groups and the risk factors associated with acquiring it, in order to show that vaccination can also be useful even after the beginning of sexual activity provided that the infection has not already been acquired.
The limitations of this study include the fact that our sample was not representative of the general Italian population, recruitment was limited to one Italian Region, a convenience sample of schools was selected and mainly upper-middle class population was included. Though the proportion of respondents to the survey was satisfactorily high, those with higher knowledge and interested by HPV-related health problems were more likely to participate in the study. These considerations are reflected by the high level of education of parents (i.e., about 40% had a university degree, as compared to 24% in the general Milan population [50]) and larger number of female than male students participating to the survey. However, when we corrected our results for educational level of the parents using post-stratification weights [51], the major findings were only marginally different (e.g., the corrected proportion of mothers and fathers who had ever heard of HPV were 88% and 75%, respectively). In addition, we could not obtain information from middle school children (i.e. those aged 10-13 years) because their school boards considered them to be too young. On the contrary, the major strengths of the study are its large size, the availability of concurrent information from both parents and children, and the inclusion of both male and female subjects.

Conclusions

In conclusion, our data highlight the fact that a better understanding of HPV infection and the possibility of preventing cancer by means of HPV vaccination could increase the acceptance of vaccination by both students and parents. This underlines the need to plan adequate educational programs. Moreover, as physicians (both pediatricians and family physicians) can play a critical role in counseling, their knowledge of HPV infection and its prevention should also be evaluated and improved if necessary.

Acknowledgements

This study was supported in part by a grant from the Pediatric Clinic I, Università degli Studi di Milano.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CP, created the database and wrote the manuscript. SE, designed the study and co-wrote the manuscript. CG, performed the statistical analysis. MS, CS, IP, SC, and GM, explained and collected the questionnaires. NP, designed the study and co-wrote the manuscript.
All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat IARC: Human papillomaviruses. Lyon. 2007, International Agency for Research on Cancer IARC: Human papillomaviruses. Lyon. 2007, International Agency for Research on Cancer
2.
Zurück zum Zitat Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008, 43 (4 Suppl): S5-S25.PubMed Smith JS, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008, 43 (4 Suppl): S5-S25.PubMed
3.
Zurück zum Zitat Gillison MR: Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008, 43 (4 Suppl): S52-S60. 10.1016/j.jadohealth.2008.07.002.CrossRefPubMedPubMedCentral Gillison MR: Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008, 43 (4 Suppl): S52-S60. 10.1016/j.jadohealth.2008.07.002.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-A33. 10.1016/j.vaccine.2008.12.028.CrossRefPubMed Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M: Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine. 2009, 27 (Suppl 1): A30-A33. 10.1016/j.vaccine.2008.12.028.CrossRefPubMed
5.
Zurück zum Zitat De Vuyst H, Clifford G, Li N, Franceschi S: HPV infection in Europe. Eur J Cancer. 2009, 45: 2632-S2639. 10.1016/j.ejca.2009.07.019.CrossRefPubMed De Vuyst H, Clifford G, Li N, Franceschi S: HPV infection in Europe. Eur J Cancer. 2009, 45: 2632-S2639. 10.1016/j.ejca.2009.07.019.CrossRefPubMed
6.
Zurück zum Zitat Trottier H, Burchell AN: Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009, 12 (5-6): 291-307. 10.1159/000214920.CrossRefPubMed Trottier H, Burchell AN: Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009, 12 (5-6): 291-307. 10.1159/000214920.CrossRefPubMed
7.
Zurück zum Zitat Friedman LS, Kahn J, Middleman AB, Rosenthal SL, Zimet GD, Society for Adolescent Medicine: Human papillomavirus (HPV) vaccine: a position statement of the Society for Adolescent Medicine. J Adolesc Health. 2006, 39: 620-10.1016/j.jadohealth.2006.07.013.CrossRefPubMed Friedman LS, Kahn J, Middleman AB, Rosenthal SL, Zimet GD, Society for Adolescent Medicine: Human papillomavirus (HPV) vaccine: a position statement of the Society for Adolescent Medicine. J Adolesc Health. 2006, 39: 620-10.1016/j.jadohealth.2006.07.013.CrossRefPubMed
8.
Zurück zum Zitat Bartolozzi G, Bona G, Ciofi M, De Martino M, Di Pietro P, Duse M, Esposito S, Gasparini R, Mariani L, Marostica G, Paravati F, Plebani A, Principi N, Zuccotti GV, Tovo PA: Human papillomavirus vaccination. Consensus Conference in pediatric age. Minerva Pediatr. 2007, 59: 165-182.PubMed Bartolozzi G, Bona G, Ciofi M, De Martino M, Di Pietro P, Duse M, Esposito S, Gasparini R, Mariani L, Marostica G, Paravati F, Plebani A, Principi N, Zuccotti GV, Tovo PA: Human papillomavirus vaccination. Consensus Conference in pediatric age. Minerva Pediatr. 2007, 59: 165-182.PubMed
9.
Zurück zum Zitat Kahn JA: An update on human papillomavirus infection and Papanicolau smears in adolescents. Curr Opin Pediatr. 2001, 13: 303-309. 10.1097/00008480-200108000-00003.CrossRefPubMed Kahn JA: An update on human papillomavirus infection and Papanicolau smears in adolescents. Curr Opin Pediatr. 2001, 13: 303-309. 10.1097/00008480-200108000-00003.CrossRefPubMed
10.
Zurück zum Zitat Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA. 2007, 297: 813-819. 10.1001/jama.297.8.813.CrossRefPubMed Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA. 2007, 297: 813-819. 10.1001/jama.297.8.813.CrossRefPubMed
11.
Zurück zum Zitat Schwarz TF, Spaczynski M, Schneider A, Wysocki J, Galaj A, Perona P, Poncelet S, Zahaf T, Hardt K, Descamps D, Dubin G, HPV Study Group for Adult Women: Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine. 2009, 27: 581-587. 10.1016/j.vaccine.2008.10.088.CrossRefPubMed Schwarz TF, Spaczynski M, Schneider A, Wysocki J, Galaj A, Perona P, Poncelet S, Zahaf T, Hardt K, Descamps D, Dubin G, HPV Study Group for Adult Women: Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine. 2009, 27: 581-587. 10.1016/j.vaccine.2008.10.088.CrossRefPubMed
13.
Zurück zum Zitat Munoz N, Manalastas R, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet. 2009, 373: 1949-1957. 10.1016/S0140-6736(09)60691-7.CrossRefPubMed Munoz N, Manalastas R, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. Lancet. 2009, 373: 1949-1957. 10.1016/S0140-6736(09)60691-7.CrossRefPubMed
14.
Zurück zum Zitat Castellsague X, Schneider A, Kaufmann AM, Bosch FX: HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol. 2009, 115: S15-S23. 10.1016/j.ygyno.2009.09.021.CrossRefPubMed Castellsague X, Schneider A, Kaufmann AM, Bosch FX: HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol. 2009, 115: S15-S23. 10.1016/j.ygyno.2009.09.021.CrossRefPubMed
15.
Zurück zum Zitat Esposito S, Bosis S, Pelucchi C, Begliatti E, Rognoni A, Bellasio M, Tel F, Consolo S, Principi N: Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine. 2007, 25: 6437-6646. 10.1016/j.vaccine.2007.06.053.CrossRefPubMed Esposito S, Bosis S, Pelucchi C, Begliatti E, Rognoni A, Bellasio M, Tel F, Consolo S, Principi N: Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine. 2007, 25: 6437-6646. 10.1016/j.vaccine.2007.06.053.CrossRefPubMed
16.
Zurück zum Zitat Brabin L, Roberts SA, Farzaneh F, Kitchener HC: Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006, 24: 3087-3094. 10.1016/j.vaccine.2006.01.048.CrossRefPubMed Brabin L, Roberts SA, Farzaneh F, Kitchener HC: Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006, 24: 3087-3094. 10.1016/j.vaccine.2006.01.048.CrossRefPubMed
17.
Zurück zum Zitat Chan SS, Yan Ng BH, Lo WK, Cheung TH, Hung Chung TK: Adolescent girls' attitudes on human papillomavirus vaccination. J Pediatr Adolesc Gynecol. 2009, 22: 85-90. 10.1016/j.jpag.2007.12.007.CrossRefPubMed Chan SS, Yan Ng BH, Lo WK, Cheung TH, Hung Chung TK: Adolescent girls' attitudes on human papillomavirus vaccination. J Pediatr Adolesc Gynecol. 2009, 22: 85-90. 10.1016/j.jpag.2007.12.007.CrossRefPubMed
18.
Zurück zum Zitat Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF: Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008, 99: 225-229. 10.1038/sj.bjc.6604454.CrossRefPubMedPubMedCentral Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF: Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer. 2008, 99: 225-229. 10.1038/sj.bjc.6604454.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Tozzi AE, Ravà L, Stat D, Pandolfi E, Marino MG, Ugazio AG: Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. Vaccine. 2009, 27: 2625-2629. 10.1016/j.vaccine.2009.02.050.CrossRefPubMed Tozzi AE, Ravà L, Stat D, Pandolfi E, Marino MG, Ugazio AG: Attitudes towards HPV immunization of Italian mothers of adolescent girls and potential role of health professionals in the immunization program. Vaccine. 2009, 27: 2625-2629. 10.1016/j.vaccine.2009.02.050.CrossRefPubMed
20.
Zurück zum Zitat Donders GG, Gabrovska M, Bellen G, et al: Knowledge of cervix cancer human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet. 2008, 277: 291-298. 10.1007/s00404-007-0487-1.CrossRefPubMed Donders GG, Gabrovska M, Bellen G, et al: Knowledge of cervix cancer human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet. 2008, 277: 291-298. 10.1007/s00404-007-0487-1.CrossRefPubMed
21.
Zurück zum Zitat Winkler JL, Wittet S, Bartolini RM, Van Keirsbilck J, Van Den Bosch T, Riphagen I, Verjans M: Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine. 2008, 26 (Suppl 11): L73-L79. 10.1016/j.vaccine.2008.05.027.CrossRefPubMed Winkler JL, Wittet S, Bartolini RM, Van Keirsbilck J, Van Den Bosch T, Riphagen I, Verjans M: Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean. Vaccine. 2008, 26 (Suppl 11): L73-L79. 10.1016/j.vaccine.2008.05.027.CrossRefPubMed
22.
Zurück zum Zitat Tozzi AE, Buonuoma PS, Ciofi degli Atti ML, Carloni E, Meloni M, Gamba F: Comparison of quality of internet pages on human papillomavirus immunization in Italian and in English. J Adolesc Health. 2010, 46: 83-89. 10.1016/j.jadohealth.2009.05.006.CrossRefPubMed Tozzi AE, Buonuoma PS, Ciofi degli Atti ML, Carloni E, Meloni M, Gamba F: Comparison of quality of internet pages on human papillomavirus immunization in Italian and in English. J Adolesc Health. 2010, 46: 83-89. 10.1016/j.jadohealth.2009.05.006.CrossRefPubMed
23.
Zurück zum Zitat Uskun E, Uskun SB, Uysalgenc M, Yagiz M: Effectiveness of a training intervention on immunization to increase knowledge of primary healthcare workers and vaccination coverage rates. Public Health. 2008, 122: 949-958. 10.1016/j.puhe.2007.10.005.CrossRefPubMed Uskun E, Uskun SB, Uysalgenc M, Yagiz M: Effectiveness of a training intervention on immunization to increase knowledge of primary healthcare workers and vaccination coverage rates. Public Health. 2008, 122: 949-958. 10.1016/j.puhe.2007.10.005.CrossRefPubMed
24.
Zurück zum Zitat Vandermeulen C, Roelants M, Theeten H, Depoorter AM, Van Damme P, Hoppenbrouwers K: Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics. 2008, 121: e428-e434. 10.1542/peds.2007-1415.CrossRefPubMed Vandermeulen C, Roelants M, Theeten H, Depoorter AM, Van Damme P, Hoppenbrouwers K: Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants. Pediatrics. 2008, 121: e428-e434. 10.1542/peds.2007-1415.CrossRefPubMed
25.
Zurück zum Zitat Paschal AM, Maryman J, Oler-Manske J: How can immunization coverage in urban counties be improved? A pilot study of a Kansas county. Am J Infect Control. 2009, 37: 423-425. 10.1016/j.ajic.2008.07.005.CrossRefPubMed Paschal AM, Maryman J, Oler-Manske J: How can immunization coverage in urban counties be improved? A pilot study of a Kansas county. Am J Infect Control. 2009, 37: 423-425. 10.1016/j.ajic.2008.07.005.CrossRefPubMed
26.
Zurück zum Zitat Baeyens JP: Ensuring the willingness to vaccinate and be vaccinated. Expert Rev Vaccines. 2010, 9 (3 Suppl): 11-14. 10.1586/erv.10.28.CrossRefPubMed Baeyens JP: Ensuring the willingness to vaccinate and be vaccinated. Expert Rev Vaccines. 2010, 9 (3 Suppl): 11-14. 10.1586/erv.10.28.CrossRefPubMed
27.
Zurück zum Zitat ISTAT: Capitolo 7. Istruzione. Annuario statistico Italiano. 2008, Rome: Istituto Nazionale di Statistica, ISTAT, 171-198. ISTAT: Capitolo 7. Istruzione. Annuario statistico Italiano. 2008, Rome: Istituto Nazionale di Statistica, ISTAT, 171-198.
28.
Zurück zum Zitat Marlow LA, Waller J, Wardle J: Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007, 25: 1945-1952. 10.1016/j.vaccine.2007.01.059.CrossRefPubMed Marlow LA, Waller J, Wardle J: Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007, 25: 1945-1952. 10.1016/j.vaccine.2007.01.059.CrossRefPubMed
29.
Zurück zum Zitat Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT: Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009, 18: 363-372. 10.1158/1055-9965.EPI-08-0418.CrossRefPubMed Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT: Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009, 18: 363-372. 10.1158/1055-9965.EPI-08-0418.CrossRefPubMed
30.
Zurück zum Zitat Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010, 7: e1000270-10.1371/journal.pmed.1000270.CrossRefPubMedPubMedCentral Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010, 7: e1000270-10.1371/journal.pmed.1000270.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Klug SJ, Hukelmann M, Blettner M: Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008, 46: 87-98. 10.1016/j.ypmed.2007.09.003.CrossRefPubMed Klug SJ, Hukelmann M, Blettner M: Knowledge about infection with human papillomavirus: a systematic review. Prev Med. 2008, 46: 87-98. 10.1016/j.ypmed.2007.09.003.CrossRefPubMed
32.
Zurück zum Zitat Christian WJ, Christian A, Hopenhayn C: Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health. 2009, 44: 437-445. 10.1016/j.jadohealth.2008.09.001.CrossRefPubMed Christian WJ, Christian A, Hopenhayn C: Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health. 2009, 44: 437-445. 10.1016/j.jadohealth.2008.09.001.CrossRefPubMed
33.
Zurück zum Zitat Lloyd GP, Marlow LA, Walter J, Miles A, Wardle J: An experimental investigation of the emotional and motivational impact of HPV information in adolescents. J Adolesc Health. 2009, 45: 532-534. 10.1016/j.jadohealth.2009.06.003.CrossRefPubMed Lloyd GP, Marlow LA, Walter J, Miles A, Wardle J: An experimental investigation of the emotional and motivational impact of HPV information in adolescents. J Adolesc Health. 2009, 45: 532-534. 10.1016/j.jadohealth.2009.06.003.CrossRefPubMed
34.
Zurück zum Zitat Liddon N, Hood J, Wynn BA, Markowitz LE: Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010, 46: 113-123. 10.1016/j.jadohealth.2009.11.199.CrossRefPubMed Liddon N, Hood J, Wynn BA, Markowitz LE: Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010, 46: 113-123. 10.1016/j.jadohealth.2009.11.199.CrossRefPubMed
35.
Zurück zum Zitat Hoglund AT, Tyden T, Hannerfors AK, Larsson M: Knowledge of human papillomavirus and attitudes to vaccination among Swedish high school students. Int J STD AIDS. 2009, 20: 102-107. 10.1258/ijsa.2008.008200.CrossRefPubMed Hoglund AT, Tyden T, Hannerfors AK, Larsson M: Knowledge of human papillomavirus and attitudes to vaccination among Swedish high school students. Int J STD AIDS. 2009, 20: 102-107. 10.1258/ijsa.2008.008200.CrossRefPubMed
36.
Zurück zum Zitat Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R: University students' knowledge and awareness of HPV. Prev Med. 1999, 28: 535-541. 10.1006/pmed.1999.0486.CrossRefPubMed Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R: University students' knowledge and awareness of HPV. Prev Med. 1999, 28: 535-541. 10.1006/pmed.1999.0486.CrossRefPubMed
37.
Zurück zum Zitat Lambert EC: College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001, 14: 178-183.PubMed Lambert EC: College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract. 2001, 14: 178-183.PubMed
38.
Zurück zum Zitat Caskey R, Lindau ST, Alexander GC: Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009, 45: 453-462. 10.1016/j.jadohealth.2009.04.021.CrossRefPubMed Caskey R, Lindau ST, Alexander GC: Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009, 45: 453-462. 10.1016/j.jadohealth.2009.04.021.CrossRefPubMed
39.
Zurück zum Zitat Moscicki AB: Impact of HPV infection in adolescent populations. J Adolesc Health. 2005, 37 (6 Suppl): S3-S9. 10.1016/j.jadohealth.2005.09.011.CrossRefPubMed Moscicki AB: Impact of HPV infection in adolescent populations. J Adolesc Health. 2005, 37 (6 Suppl): S3-S9. 10.1016/j.jadohealth.2005.09.011.CrossRefPubMed
40.
Zurück zum Zitat Printz C: CancerScope: HPV vaccine for boys and men? It could help reduce incidence of cervical and head and neck cancers. Cancer. 2009, 115: 5129-5130. 10.1002/cncr.24725.CrossRefPubMed Printz C: CancerScope: HPV vaccine for boys and men? It could help reduce incidence of cervical and head and neck cancers. Cancer. 2009, 115: 5129-5130. 10.1002/cncr.24725.CrossRefPubMed
41.
Zurück zum Zitat Smith A, Lyons A, Pitts M, Croy S, Ryall R, Garland S, Wong ML, Tay EH: Assessing knowledge of human papillomavirus and collecting data on sexual behavior: computer assisted telephone versus face to face interviews. BMC Public Health. 2009, 23: 429-10.1186/1471-2458-9-429.CrossRef Smith A, Lyons A, Pitts M, Croy S, Ryall R, Garland S, Wong ML, Tay EH: Assessing knowledge of human papillomavirus and collecting data on sexual behavior: computer assisted telephone versus face to face interviews. BMC Public Health. 2009, 23: 429-10.1186/1471-2458-9-429.CrossRef
42.
Zurück zum Zitat Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD: Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine. 2010, Epub Jan 5 Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD: Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine. 2010, Epub Jan 5
43.
Zurück zum Zitat Mortensen GL: Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health. 2010, 10: 68-10.1186/1471-2458-10-68.CrossRefPubMedPubMedCentral Mortensen GL: Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health. 2010, 10: 68-10.1186/1471-2458-10-68.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Roberts ME, Gerrard M, Reimer R, Gibbons FX: Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010, 125: 982-989. 10.1542/peds.2009-2888.CrossRefPubMed Roberts ME, Gerrard M, Reimer R, Gibbons FX: Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010, 125: 982-989. 10.1542/peds.2009-2888.CrossRefPubMed
45.
Zurück zum Zitat Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD: A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010, Epub Apr 20 Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD: A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010, Epub Apr 20
46.
Zurück zum Zitat Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007, 45: 107-114. 10.1016/j.ypmed.2007.05.013.CrossRefPubMed Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007, 45: 107-114. 10.1016/j.ypmed.2007.05.013.CrossRefPubMed
47.
Zurück zum Zitat Gerend MA, Magloire ZF: Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008, 42: 237-242. 10.1016/j.jadohealth.2007.08.022.CrossRefPubMed Gerend MA, Magloire ZF: Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health. 2008, 42: 237-242. 10.1016/j.jadohealth.2007.08.022.CrossRefPubMed
48.
Zurück zum Zitat Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA: Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008, 43: 239-245. 10.1016/j.jadohealth.2008.06.009.CrossRefPubMed Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA: Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008, 43: 239-245. 10.1016/j.jadohealth.2008.06.009.CrossRefPubMed
49.
Zurück zum Zitat Gottlieb SL, Brewer NT, Smith JS, Keating KM, Markowitz LE: Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer. J Adolesc Health. 2009, 45: 438-444. 10.1016/j.jadohealth.2009.05.013.CrossRefPubMed Gottlieb SL, Brewer NT, Smith JS, Keating KM, Markowitz LE: Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer. J Adolesc Health. 2009, 45: 438-444. 10.1016/j.jadohealth.2009.05.013.CrossRefPubMed
50.
Zurück zum Zitat AMMA: Rapporto sull'habitat urbano del Comune di Milano. Milan. 2006, Agenzia Milanese Mobilità Ambiente AMMA: Rapporto sull'habitat urbano del Comune di Milano. Milan. 2006, Agenzia Milanese Mobilità Ambiente
51.
Zurück zum Zitat Jagers P: Post-stratification against bias in sampling. Int Stat Rev. 1986, 54: 159-167. 10.2307/1403141.CrossRef Jagers P: Post-stratification against bias in sampling. Int Stat Rev. 1986, 54: 159-167. 10.2307/1403141.CrossRef
Metadaten
Titel
Knowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern Italy
verfasst von
Claudio Pelucchi
Susanna Esposito
Carlotta Galeone
Margherita Semino
Caterina Sabatini
Irene Picciolli
Silvia Consolo
Gregorio Milani
Nicola Principi
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2010
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-378

Weitere Artikel der Ausgabe 1/2010

BMC Public Health 1/2010 Zur Ausgabe